Enbrel and Immunodeficiency common variable - a phase IV clinical study of FDA data

Summary:

Immunodeficiency common variable is reported as a side effect among people who take Enbrel (etanercept), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Neurontin, and have Cataplexy.

The phase IV clinical study analyzes which people have Immunodeficiency common variable when taking Enbrel. It is created by eHealthMe based on reports of 662,905 people who have side effects when taking Enbrel from the FDA, and is updated regularly.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.

What is Immunodeficiency common variable?

Immunodeficiency common variable is found to be associated with 86 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.

On Jul, 23, 2026

662,905 people reported to have side effects when taking Enbrel.
Among them, 16 people (0.0%) have Immunodeficiency common variable.

Could Enbrel cause Immunodeficiency common variable?

Among these 16 people:

How long have people been on Enbrel when they have Immunodeficiency common variable? *

What is the gender of people who have Immunodeficiency common variable when taking Enbrel? *

female: 80 %
male: 20 %

What is the age of people who have Immunodeficiency common variable when taking Enbrel? *

What are other drugs people take besides Enbrel? *

What are other side effects people have besides Immunodeficiency common variable? *

Head Injury: 4 people, 25.00%
Sinusitis (inflammation of sinus): 3 people, 18.75%
Weight Increased: 2 people, 12.50%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 12.50%
Kidney Stones: 2 people, 12.50%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 12.50%
Indigestion: 2 people, 12.50%
Hot Flush (sudden feelings of heat): 2 people, 12.50%
Gastrointestinal Infection (infection of stomach and intestine): 2 people, 12.50%
Muscle Spasms (muscle contraction): 2 people, 12.50%

What are the existing conditions these people have? *

Upper Respiratory Tract Infection: 2 people, 12.50%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 12.50%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 12.50%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Immunodeficiency common variable?

- Check whether Immunodeficiency common variable is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enbrel:

Enbrel (664,678 reports)

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunodeficiency common variable:

Immunodeficiency common variable (86 drugs)

Browse all the conditions that are associated with Immunodeficiency common variable:

Immunodeficiency common variable (143 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.